相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Guidance on the use of adalimumab for juvenile idiopathic arthritis in Japan
Shumpei Yokota et al.
Modern Rheumatology (2014)
One-year maintenance outcomes among patients with moderately-to-severely active ulcerative colitis who responded to induction therapy with adalimumab: subgroup analyses from ULTRA 2
W. J. Sandborn et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective
Fabien B. Vincent et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1)
Joachim Sieper et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease
Gerd R. Burmester et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: Results from the CARE trial
Edouard Louis et al.
JOURNAL OF CROHNS & COLITIS (2013)
Subgroup analysis of the placebo-controlled CHARM trial: Increased remission rates through 3 years for adalimumab-treated patients with early Crohn's disease
S. Schreiber et al.
JOURNAL OF CROHNS & COLITIS (2013)
Small Intestine Contrast Ultrasonography in Pediatric Crohn's Disease
Nadia Pallotta et al.
JOURNAL OF PEDIATRICS (2013)
Safety and Efficacy of Infliximab and Adalimumab for Refractory Uveitis in Juvenile Idiopathic Arthritis: 1-year Followup Data from the Italian Registry
Maria E. Zannin et al.
JOURNAL OF RHEUMATOLOGY (2013)
Anti-drug antibodies, auto-antibodies and biotherapy in psoriasis
D. Jullien
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE (2012)
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011
D. E. Furst et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Anti-TNF Monoclonal Antibodies in Inflammatory Bowel Disease: Pharmacokinetics-Based Dosing Paradigms
Ingrid Ordas et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan
Tomoyuki Imagawa et al.
CLINICAL RHEUMATOLOGY (2012)
Safety and Efficacy of Adalimumab for Moderate to Severe Crohn's Disease in Children
Jeffrey S. Hyams et al.
GASTROENTEROLOGY (2012)
Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
William J. Sandborn et al.
GASTROENTEROLOGY (2012)
Adalimumab produces clinical remission and reduces extraintestinal manifestations in Crohn's disease: Results from CARE
Robert Lofberg et al.
INFLAMMATORY BOWEL DISEASES (2012)
The effects of anti-TNF-α treatment with adalimumab on growth in children with Crohn's disease (CD)
S. Malik et al.
JOURNAL OF CROHNS & COLITIS (2012)
COMPREHENSIVE VALUE ESTIMATION OF ADALIMUMAB-BASED TREATMENTS: COVET STUDY
F. S. Mennini et al.
VALUE IN HEALTH (2012)
SOCIAL IMPACT OF ADALIMUMAB IN THE ITALIAN PERSPECTIVE
A. Marcellusi et al.
VALUE IN HEALTH (2012)
2012 Update of the 2008 American College of Rheumatology Recommendations for the Use of Disease-Modifying Antirheumatic Drugs and Biologic Agents in the Treatment of Rheumatoid Arthritis
Jasvinder A. Singh et al.
ARTHRITIS CARE & RESEARCH (2012)
Ulcerative colitis and rheumatoid arthritis: a rare association - case report
Vitor Alves Cruz et al.
REVISTA BRASILEIRA DE REUMATOLOGIA (2012)
Association of paediatric inflammatory bowel disease with other immune-mediated diseases
Michael D. Kappelman et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2011)
Anti-TNF therapy
Nishanthi Thalayasingam et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2011)
Effect of adalimumab on work productivity and indirect costs in moderate to severe Crohn's disease: A meta-analysis
David G. Binion et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY (2011)
New IBD genetics: common pathways with other diseases
C. W. Lees et al.
GUT (2011)
Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor: a systematic review and economic evaluation
K. Malottki et al.
HEALTH TECHNOLOGY ASSESSMENT (2011)
ADALIMUMAB FOR THE TREATMENT OF IMMUNE-MEDIATED DISEASES: AN UPDATE ON OLD AND RECENT INDICATIONS
G. Murdaca et al.
DRUGS OF TODAY (2011)
Long-term efficacy of adalimumab in the treatment of uveitis associated with juvenile idiopathic arthritis
Kaisu Kotaniemi et al.
CLINICAL OPHTHALMOLOGY (2011)
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Association of Ankylosing Spondylitis and Crohn's Disease Successfully Treated with Infliximab
Ana Rebelo et al.
BIODRUGS (2010)
Pharmacology of TNF blockade in rheumatoid arthritis and other chronic inflammatory diseases
Peter C. Taylor
CURRENT OPINION IN PHARMACOLOGY (2010)
Adalimumab Treatment in Children with Refractory Crohn's Disease
Yoram Rosenbach et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Anti-TNF-α agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls
Leia C. R. Silva et al.
IMMUNOTHERAPY (2010)
Long-term efficacy of adalimumab in Paediatric Crohn's disease patients naive to other anti-TNF therapies
J. Martin-de-Carpi et al.
JOURNAL OF CROHNS & COLITIS (2010)
Clinical manifestations and responsiveness to adalimumab are similar in patients with ankylosing spondylitis with and without concomitant psoriasis
Juergen Braun et al.
RHEUMATOLOGY (2010)
Successful treatment with adalimumab in a patient with coexisting Beh‡et's disease and ankylosing spondylitis
Necmettin Yildiz et al.
RHEUMATOLOGY INTERNATIONAL (2010)
Effectiveness of adalimumab in treating patients with ankylosing spondylitis associated with enthesitis and peripheral arthritis
Martin Rudwaleit et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy
Martin Rudwaleit et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Tumor Necrosis Factor Inhibitors in the Management of Juvenile Idiopathic Arthritis
Susan Shenoi et al.
PEDIATRIC DRUGS (2010)
Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (RESEAT) in Pediatric Crohn's Disease
Joel R. Rosh et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Efficacy of Adalimumab in Moderate-to-Severe Pediatric Crohn's Disease
Franca Viola et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial
D. van der Heijde et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases
G. R. Burmester et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study
M. Rudwaleit et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Use of adalimumab in patients with juvenile idiopathic arthritis refractory to etanercept and/or infliximab
Maria M. Katsicas et al.
CLINICAL RHEUMATOLOGY (2009)
Psoriasis associated with ulcerative colitis and Crohn's disease
A. D. Cohen et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2009)
Detecting shared pathogenesis from the shared genetics of immune-related diseases
Alexandra Zhernakova et al.
NATURE REVIEWS GENETICS (2009)
Current treatment of inflammatory bowel disease in children
J. Markowitz
DIGESTIVE AND LIVER DISEASE (2008)
Adalimumab with or without methotrexate in juvenile rheumatoid arthritis
Daniel J. Lovell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION)
J. -H. Saurat et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Adalimumab in juvenile idiopathic arthritis-associated chronic anterior uveitis
P. Tynjala et al.
RHEUMATOLOGY (2008)
Prevalence of and annual ambulatory health care visits for pediatric arthritis and other rheumatologic conditions in the United States in 2001-2004
Jeffrey J. Sacks et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern california-managed care organization
Xiaoping Weng et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Adalimumab for long-term treatment of psoriatic arthritis - Forty-eight week data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial
Dafna D. Gladman et al.
ARTHRITIS AND RHEUMATISM (2007)
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial
Jean-Frederic Colombel et al.
GASTROENTEROLOGY (2007)
Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution
Annabel Kuek et al.
POSTGRADUATE MEDICAL JOURNAL (2007)
Clinical response to alimumab treatment in patients with moderate to severe psoriasis: Double-blind, randomized controlled trial and open-label extension study
Kenneth B. Gordon et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Efficacy and safety of adalimumab in patients with ankylosing spondylitis - Results of a multicenter, randomized, double-blind, placebo-controlled trial
Desiree van der Heijde et al.
ARTHRITIS AND RHEUMATISM (2006)
The PREMIER study - A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
FC Breedveld et al.
ARTHRITIS AND RHEUMATISM (2006)
Children with early-onset inflammatory bowel disease (IBD): Analysis of a pediatric IBD Consortium Registry
MB Heyman et al.
JOURNAL OF PEDIATRICS (2005)
Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy - A randomized, placebo-controlled, 52-week trial
EC Keystone et al.
ARTHRITIS AND RHEUMATISM (2004)
Tumour necrosis factor a as a therapeutic target for immune-mediated inflammatory diseases
PC Taylor et al.
CURRENT OPINION IN BIOTECHNOLOGY (2004)
Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: A statewide population-based study
S Kugathasan et al.
JOURNAL OF PEDIATRICS (2003)
Connections between psoriasis and Crohn's disease
DJ Najarian et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2003)
Adalimumab, a fully human anti-tumor necrosis factor a monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate - The ARMADA trial
ME Weinblatt et al.
ARTHRITIS AND RHEUMATISM (2003)
Rheumatoid arthritis, associated with ulcerative colitis
JA Mosquera-Martinez
ANNALS OF THE RHEUMATIC DISEASES (2001)
The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population-based study (the IBSEN study)
O Palm et al.
RHEUMATOLOGY (2001)
分享论文
